Leading-edge solutions for preclinical and clinical research
Stem Cell, Drug Discovery, and Analytical Services
What's New
New products for MSC research
REPROCELL offers a variety of ready-to-ship products to support Mesenchymal Stem Cell (MSC) research, including iPSC-derived cell lines, media, and other culture reagents. Our cell lines are useful for differentiation and exosome production to promote a variety of disease models for research.
Clinical MSC production service
Mesenchymal Stem Cells (MSCs) are involved in a variety of cell therapy and drug discovery programs. REPROCELL can help you drive your next clinical MSC project to success and ensure compliancy with regulatory agencies.
The REPROCELL Blog
Latest
Harnessing the Power of Mesenchymal Stem Cells
27 May 2024
What to consider when selecting a central laboratory provider
07 May 2024
Leveraging Human Tissue Models with Preclinical and Drug Discovery CRO
05 April 2024
ec23: A Promising ATRA Alternative for Advancing Stem Cell Research
13 December 2023
Quality Control: What is really in your hiPSC culture?
11 December 2023
Upcoming Events
Conferences and meetings we will be attending, and webinars hosted by us.
REPROCELL Corporate News
PRESS RELEASE: Bioserve Biotechnologies and RISVI Trading Announce New Distributorship Agreement in Qatar
17 May 2024
PRESS RELEASE: Our StemRNA Clinical Seed iPSCs Power Breakthrough in Women's Health!
16 May 2024
PRESS RELEASE: REPROCELL Announces Partnership with Nova Natura UAB, Expanding Distribution Reach in Baltic Region
14 May 2024